A large pharmaceutical company was engaged in licensing negotiation with a small biotech firm over the terms of a technology transfer.

When the talks reached a standstill over royalty rates, the two sides began an all-weekend marathon session.

Each side came armed with supporting arguments and data, but, by Sunday afternoon, they had failed to converge toward the center.